Fate Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Fate Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 41,249,000 | 44,920,000 | 36,056,000 | 37,909,000 | 36,917,000 | 121,322,000 | 41,870,000 | 33,334,000 | 46,802,000 | 42,020,000 | 61,333,000 | 82,093,000 | 55,275,000 | 64,741,000 | 133,583,000 | 129,180,000 | 76,654,000 | 106,413,000 | 167,347,000 | 349,130,000 | 433,074,000 | 83,366,000 | 99,814,000 | 249,588,000 | 71,435,000 | 183,033,000 | 190,514,000 | 183,247,000 | 36,162,000 | 32,912,000 | 88,952,000 | 43,231,000 | 31,063,000 | 40,608,000 | 88,609,000 | 37,099,000 | 35,870,000 | 39,487,000 | 64,809,000 | 72,857,000 | 81,176,000 | 42,349,000 | 45,530,000 | 42,012,000 | 47,881,000 | 19,082,000 |
| accounts receivable | 1,395,000 | 2,406,000 | 3,539,000 | 4,127,000 | 1,048,000 | 858,000 | 1,826,000 | 1,538,000 | 2,833,000 | 13,500,000 | 38,480,000 | 10,223,000 | 13,126,000 | 13,850,000 | 8,676,000 | 7,311,000 | 10,303,000 | 6,945,000 | 5,515,000 | 3,243,000 | 1,717,000 | 500,000 | 500,000 | 500,000 | 500,000 | 846,000 | ||||||||||||||||||||
| short-term investments | 181,581,000 | 195,505,000 | 243,012,000 | 259,014,000 | 267,962,000 | 262,222,000 | 273,305,000 | 374,894,000 | 39,950,000 | 41,692,000 | 3,503,000 | 9,520,000 | 10,060,000 | 16,125,000 | ||||||||||||||||||||||||||||||||
| prepaid expenses and other current assets | 6,172,000 | 5,386,000 | 9,302,000 | 9,244,000 | 13,461,000 | 9,973,000 | 14,539,000 | 12,902,000 | 11,414,000 | 15,490,000 | 27,367,000 | 19,970,000 | 17,181,000 | 11,453,000 | 8,826,000 | 7,701,000 | 7,369,000 | 7,236,000 | 5,892,000 | 4,729,000 | 5,099,000 | 4,965,000 | 5,662,000 | 2,810,000 | 3,170,000 | 2,897,000 | 3,689,000 | 2,237,000 | 2,015,000 | 1,491,000 | 1,647,000 | 825,000 | 848,000 | 1,137,000 | 1,211,000 | 780,000 | 1,162,000 | 955,000 | 843,000 | 482,000 | 395,000 | 443,000 | 94,000 | 233,000 | 382,000 | 304,000 |
| total current assets | 230,397,000 | 248,217,000 | 291,909,000 | 310,294,000 | 319,388,000 | 394,375,000 | 331,540,000 | 364,174,000 | 392,182,000 | 437,888,000 | 502,074,000 | 535,329,000 | 599,157,000 | 599,075,000 | 633,412,000 | 693,713,000 | 713,268,000 | 804,316,000 | 494,323,000 | 496,777,000 | 540,225,000 | 208,249,000 | 227,089,000 | 305,633,000 | 165,178,000 | 186,430,000 | 205,196,000 | 213,929,000 | 80,034,000 | 90,625,000 | 102,596,000 | 70,039,000 | 71,861,000 | 83,437,000 | 93,323,000 | 47,399,000 | 47,092,000 | 56,567,000 | 65,652,000 | 74,185,000 | 81,571,000 | 42,792,000 | 45,624,000 | 42,245,000 | 48,263,000 | 19,386,000 |
| long-term investments | 26,097,000 | 32,286,000 | 27,657,000 | 33,607,000 | 47,162,000 | 7,595,000 | 980,000 | 7,291,000 | 3,912,000 | 4,942,000 | 13,939,000 | 11,925,000 | 67,942,000 | 100,664,000 | 124,877,000 | 149,501,000 | 98,284,000 | 13,233,000 | 16,139,000 | 39,440,000 | ||||||||||||||||||||||||||
| property and equipment | 61,097,000 | 62,762,000 | 64,384,000 | 82,392,000 | 87,534,000 | 92,116,000 | 96,836,000 | 101,707,000 | 106,331,000 | 108,594,000 | 110,020,000 | 109,118,000 | 103,116,000 | 97,857,000 | 91,529,000 | 74,617,000 | 59,213,000 | 47,950,000 | 32,308,000 | 20,710,000 | 15,932,000 | 11,896,000 | 11,419,000 | 9,653,000 | 9,225,000 | 8,402,000 | 5,125,000 | 3,798,000 | 2,894,000 | 2,649,000 | 2,550,000 | 2,490,000 | 1,945,000 | 1,746,000 | 1,579,000 | 1,750,000 | 1,940,000 | 1,992,000 | 2,160,000 | 2,072,000 | 1,766,000 | 1,544,000 | 1,240,000 | 1,159,000 | 1,264,000 | 789,000 |
| operating lease right-of-use assets | 43,814,000 | 45,178,000 | 46,508,000 | 58,441,000 | 59,547,000 | 60,620,000 | 61,675,000 | 62,721,000 | 63,743,000 | 64,682,000 | 66,069,000 | 67,378,000 | 68,493,000 | 69,475,000 | 70,720,000 | 64,970,000 | 66,184,000 | 67,295,000 | 67,084,000 | 67,130,000 | 68,229,000 | 69,200,000 | 22,752,000 | 23,160,000 | 23,560,000 | 23,955,000 | ||||||||||||||||||||
| restricted cash | 10,227,000 | 10,227,000 | 10,227,000 | 10,227,000 | 15,177,000 | 15,177,000 | 15,177,000 | 15,177,000 | 15,177,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 15,227,000 | 227,000 | 227,000 | 227,000 | 227,000 | 227,000 | 227,000 | 227,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 | 122,000 |
| other assets | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 526,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 32,000 | 24,000 | 25,000 | 2,743,000 | |||||||
| total assets | 371,632,000 | 398,670,000 | 440,694,000 | 494,970,000 | 528,817,000 | 569,892,000 | 506,217,000 | 543,788,000 | 584,757,000 | 630,336,000 | 705,561,000 | 749,349,000 | 807,059,000 | 858,386,000 | 921,455,000 | 984,571,000 | 1,015,666,000 | 1,045,964,000 | 622,457,000 | 626,443,000 | 653,594,000 | 321,890,000 | 302,274,000 | 340,207,000 | 199,877,000 | 220,865,000 | 213,032,000 | 219,954,000 | 83,155,000 | 93,420,000 | 105,292,000 | 72,675,000 | 73,952,000 | 85,329,000 | 95,048,000 | 49,295,000 | 49,178,000 | 58,705,000 | 67,958,000 | 76,403,000 | 83,483,000 | 44,490,000 | 47,010,000 | 43,551,000 | 49,649,000 | 23,040,000 |
| liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 4,040,000 | 4,190,000 | 9,365,000 | 6,349,000 | 5,495,000 | 6,765,000 | 4,719,000 | 5,706,000 | 7,506,000 | 9,855,000 | 8,265,000 | 9,593,000 | 8,420,000 | 11,444,000 | 8,612,000 | 6,439,000 | 5,771,000 | 8,998,000 | 6,283,000 | 3,717,000 | 13,563,000 | 5,173,000 | 5,822,000 | 5,715,000 | 5,410,000 | 5,367,000 | 4,205,000 | 5,236,000 | 3,510,000 | 2,160,000 | 1,678,000 | 2,198,000 | 1,177,000 | 2,470,000 | 934,000 | 1,200,000 | 1,998,000 | 1,975,000 | 996,000 | 1,280,000 | 1,507,000 | 1,271,000 | 1,157,000 | 980,000 | 1,330,000 | |
| accrued expenses | 18,182,000 | 17,213,000 | 21,348,000 | 23,580,000 | 22,654,000 | 32,043,000 | 27,514,000 | 28,540,000 | 29,469,000 | 31,513,000 | 53,932,000 | 50,149,000 | 40,524,000 | 35,110,000 | 42,412,000 | 54,003,000 | 25,736,000 | 20,931,000 | 15,564,000 | 14,782,000 | 11,618,000 | 11,770,000 | 14,697,000 | 13,843,000 | 9,834,000 | 9,950,000 | 10,926,000 | 9,638,000 | 8,376,000 | 7,440,000 | 7,254,000 | 5,413,000 | 4,769,000 | 4,699,000 | 3,957,000 | 3,343,000 | 2,355,000 | 2,038,000 | 2,439,000 | 2,317,000 | 2,491,000 | 1,827,000 | 2,010,000 | 1,948,000 | 1,641,000 | 137,000 |
| cirm award liability, current portion | 795,000 | 4,000,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,160,000 | 3,160,000 | 3,160,000 | 2,808,000 | 2,106,000 | 2,106,000 | 2,106,000 | |||||||||||||||||||||||||||||
| deferred revenue | 212,000 | 393,000 | 600,000 | 159,000 | 685,000 | 1,110,000 | 1,929,000 | 7,500,000 | 8,000,000 | 198,000 | 724,000 | 1,250,000 | 1,776,000 | 2,303,000 | 2,829,000 | 3,355,000 | 3,881,000 | 4,408,000 | 4,934,000 | 5,460,000 | 5,986,000 | |||||||||||||||||||||||||
| operating lease liabilities, current portion | 5,656,000 | 6,544,000 | 7,416,000 | 6,893,000 | 6,644,000 | 6,402,000 | 6,176,000 | 5,977,000 | 5,786,000 | 5,545,000 | 5,628,000 | 5,755,000 | 5,717,000 | 5,582,000 | 5,577,000 | 4,697,000 | 5,068,000 | 4,412,000 | 3,355,000 | 2,330,000 | 2,355,000 | 1,898,000 | 1,692,000 | 1,632,000 | 1,572,000 | 1,200,000 | ||||||||||||||||||||
| total current liabilities | 28,673,000 | 28,159,000 | 38,522,000 | 37,422,000 | 34,793,000 | 45,369,000 | 39,094,000 | 41,333,000 | 44,690,000 | 48,651,000 | 114,051,000 | 103,938,000 | 91,518,000 | 77,911,000 | 81,284,000 | 91,884,000 | 105,600,000 | 94,577,000 | 85,564,000 | 54,195,000 | 45,322,000 | 24,924,000 | 27,806,000 | 40,595,000 | 29,418,000 | 29,140,000 | 27,263,000 | 22,672,000 | 16,273,000 | 12,588,000 | 11,049,000 | 9,716,000 | 8,052,000 | 16,897,000 | 15,187,000 | 14,678,000 | 14,327,000 | 13,886,000 | 13,441,000 | 12,596,000 | 11,315,000 | 6,413,000 | 3,912,000 | 3,812,000 | 4,354,000 | 9,491,000 |
| cirm award liability, net of current portion | 5,600,000 | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 | 790,000 | 790,000 | 790,000 | 702,000 | 1,404,000 | 1,404,000 | 1,404,000 | 1,404,000 | 856,000 | ||||||||||||||||||||||||||||
| operating lease liabilities, net of current portion | 75,675,000 | 76,785,000 | 77,849,000 | 92,085,000 | 93,918,000 | 95,668,000 | 97,360,000 | 98,977,000 | 100,562,000 | 102,070,000 | 103,710,000 | 105,164,000 | 106,587,000 | 107,939,000 | 109,241,000 | 104,360,000 | 105,405,000 | 106,512,000 | 93,943,000 | 83,156,000 | 78,683,000 | 73,834,000 | 25,235,000 | 25,670,000 | 26,098,000 | 26,517,000 | ||||||||||||||||||||
| stock price appreciation milestones | 320,000 | 247,000 | 527,000 | 1,197,000 | 1,184,000 | 2,740,000 | 1,346,000 | 701,000 | 1,750,000 | 2,143,000 | 9,037,000 | 9,928,000 | 15,809,000 | |||||||||||||||||||||||||||||||||
| commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2025 and december 31, 2024; class a convertible preferred shares issued and outstanding— 2,755,086 at june 30, 2025 and december 31, 2024 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| common stock | 115,000 | 115,000 | 114,000 | 114,000 | 114,000 | 114,000 | 99,000 | 99,000 | 99,000 | 98,000 | 97,000 | 97,000 | 97,000 | 97,000 | 96,000 | 95,000 | 94,000 | 94,000 | 88,000 | 87,000 | 87,000 | 76,000 | 76,000 | 75,000 | 65,000 | 65,000 | 65,000 | 65,000 | 53,000 | 53,000 | 53,000 | 41,000 | 41,000 | 41,000 | 41,000 | 34,000 | 29,000 | 29,000 | 29,000 | 29,000 | 29,000 | 21,000 | 21,000 | 21,000 | 20,000 | 1,000 |
| additional paid-in capital | 1,730,869,000 | 1,723,715,000 | 1,716,335,000 | 1,707,215,000 | 1,695,450,000 | 1,685,928,000 | 1,580,032,000 | 1,570,784,000 | 1,560,680,000 | 1,547,702,000 | 1,536,497,000 | 1,515,597,000 | 1,494,642,000 | 1,470,916,000 | 1,448,584,000 | 1,430,769,000 | 1,409,214,000 | 1,392,279,000 | 941,216,000 | 927,784,000 | 918,535,000 | 636,062,000 | 628,200,000 | 623,156,000 | 455,999,000 | 450,925,000 | 443,244,000 | 304,371,000 | 297,885,000 | 252,019,000 | 250,825,000 | 249,820,000 | 193,242,000 | 182,258,000 | 181,445,000 | 179,904,000 | 179,097,000 | 141,503,000 | 139,714,000 | 139,173,000 | 138,646,000 | 14,367,000 | ||||
| accumulated other comprehensive income | 62,000 | 191,000 | 268,000 | 835,000 | -422,000 | -194,000 | 15,000 | 3,000 | 11,000 | 14,000 | ||||||||||||||||||||||||||||||||||||
| accumulated deficit | -1,469,685,000 | -1,435,615,000 | -1,397,994,000 | -1,345,841,000 | -1,298,163,000 | -1,259,736,000 | -1,211,732,000 | -1,167,610,000 | -1,122,440,000 | -1,069,685,000 | -1,050,804,000 | -994,441,000 | -910,878,000 | -834,773,000 | -769,083,000 | -700,462,000 | -657,154,000 | -602,021,000 | -556,932,000 | -503,821,000 | -445,137,000 | -417,065,000 | -383,545,000 | -355,243,000 | -328,634,000 | -305,156,000 | -285,396,000 | -269,369,000 | -252,587,000 | -232,933,000 | -218,798,000 | -206,301,000 | -195,617,000 | -185,972,000 | -175,846,000 | -167,906,000 | -159,169,000 | -150,761,000 | -142,384,000 | |||||||
| total stockholders’ equity | 261,364,000 | 288,409,000 | 318,726,000 | 362,326,000 | 396,982,000 | 426,115,000 | 368,417,000 | 402,777,000 | 437,755,000 | 477,472,000 | 483,939,000 | 518,003,000 | 580,483,000 | 633,393,000 | 678,838,000 | 730,332,000 | 752,071,000 | 790,095,000 | 384,445,000 | 424,365,000 | 474,111,000 | 219,218,000 | 244,756,000 | 268,042,000 | 127,526,000 | 145,837,000 | 160,469,000 | 173,929,000 | 51,825,000 | 64,995,000 | 77,189,000 | 45,749,000 | 55,213,000 | 63,858,000 | 73,154,000 | 25,373,000 | 23,129,000 | 30,727,000 | 38,038,000 | 44,995,000 | 51,074,000 | 21,251,000 | 33,576,000 | 39,638,000 | 45,177,000 | |
| total liabilities and stockholders’ equity | 371,632,000 | 398,670,000 | 440,694,000 | 494,970,000 | 528,817,000 | 569,892,000 | 506,217,000 | 543,788,000 | 584,757,000 | 630,336,000 | 705,561,000 | 749,349,000 | 807,059,000 | 858,386,000 | 921,455,000 | 984,571,000 | 1,015,666,000 | 1,045,964,000 | 622,457,000 | 626,443,000 | 653,594,000 | 321,890,000 | 302,274,000 | 340,207,000 | 199,877,000 | 220,865,000 | 213,032,000 | 219,954,000 | 83,155,000 | 93,420,000 | 105,292,000 | 72,675,000 | 73,952,000 | 85,329,000 | 95,048,000 | 49,295,000 | 49,178,000 | 58,705,000 | 67,958,000 | 76,403,000 | 83,483,000 | 44,490,000 | 49,649,000 | |||
| cirm award liability | 5,070,000 | 5,070,000 | 1,940,000 | 1,940,000 | 600,000 | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000; class a convertible preferred shares issued and outstanding— 2,755,086 at march 31, 2025 and december 31, 2024 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000; class a convertible preferred shares issued and outstanding—2,755,086 at december 31, 2024 and 2,761,108 at december 31, 2023 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000; class a convertible preferred shares issued and outstanding— 2,761,108 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2024 and december 31, 2023; class a convertible preferred shares issued and outstanding— 2,761,108 at june 30, 2024 and december 31, 2023 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2024 and december 31, 2023; class a convertible preferred shares issued and outstanding—2,761,108 at march 31, 2024 and december 31, 2023 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| collaboration contract assets | 7,196,000 | 8,325,000 | 9,108,000 | 8,777,000 | 9,870,000 | 11,158,000 | 12,264,000 | 12,883,000 | 13,506,000 | 13,357,000 | 13,972,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000; class a convertible preferred shares issued and outstanding—2,761,108 at december 31, 2023 and 2,794,549 at december 31, 2022 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| short-term investments and related maturity receivables | 316,400,000 | 331,133,000 | 366,878,000 | 423,043,000 | 513,575,000 | 509,031,000 | 482,327,000 | 549,521,000 | 618,942,000 | 683,722,000 | 315,569,000 | 139,675,000 | 100,335,000 | 119,918,000 | 121,613,000 | 53,235,000 | 90,573,000 | 10,493,000 | 27,945,000 | 41,857,000 | 55,722,000 | 11,997,000 | 25,983,000 | |||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2023 and december 31, 2022; class a convertible preferred shares issued and outstanding—2,761,108 at september 30, 2023 and 2,794,549 december 31, 2022 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -499,000 | -587,000 | -646,000 | -1,854,000 | -3,253,000 | -3,381,000 | -2,850,000 | -2,000 | -14,000 | -15,000 | -13,000 | -3,000 | -13,000 | -39,000 | -34,000 | -1,000 | ||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2023 and december 31, 2022; class a convertible preferred shares issued and outstanding—2,761,108 at june 30, 2023 and 2,794,549 december 31, 2022 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, current portion | 1,738,000 | 42,226,000 | 35,241,000 | 33,657,000 | 22,575,000 | 21,483,000 | 23,545,000 | 23,032,000 | 21,033,000 | 21,144,000 | 17,121,000 | 14,626,000 | 2,923,000 | 2,787,000 | 3,367,000 | 5,049,000 | 6,576,000 | |||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2023 and december 31, 2022; class a convertible preferred shares issued and outstanding—2,794,549 at march 31, 2023 and december 31, 2022 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, net of current portion | 12,407,000 | 17,743,000 | 22,534,000 | 27,124,000 | 32,563,000 | 38,925,000 | 43,025,000 | 46,021,000 | 49,378,000 | 54,688,000 | 3,124,000 | 3,775,000 | 4,496,000 | 5,244,000 | 6,380,000 | |||||||||||||||||||||||||||||||
| stock price appreciation milestones, net of current portion | 3,861,000 | 24,168,000 | 24,632,000 | 12,865,000 | 10,955,000 | 11,684,000 | 14,559,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2022 and december 31, 2021; class a convertible preferred shares issued and outstanding—2,794,549 at december 31, 2022 and december 31, 2021 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2022 and december 31, 2021; class a convertible preferred shares issued and outstanding—2,794,549 at september 30, 2022 and december 31, 2021 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2022 and december 31, 2021; class a convertible preferred shares issued and outstanding—2,794,549 at june 30, 2022 and december 31, 2021 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2022 and december 31, 2021; class a convertible preferred shares issued and outstanding—2,794,549 at march 31, 2022 and december 31, 2021 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| stock price appreciation milestones, current portion | 42,793,000 | 36,003,000 | 36,018,000 | 13,085,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2021 and december 31, 2020; class a convertible preferred shares issued and outstanding—2,794,549 at december 31, 2021 and december 31, 2020 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive gain | -762,000 | -73,000 | -86,000 | -260,000 | 70,000 | 312,000 | 623,000 | 142,000 | 22,000 | 51,000 | 93,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2021 and december 31, 2020; class a convertible preferred shares issued and outstanding—2,794,549 at september 30, 2021 and december 31, 2020 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2021 and december 31, 2020; class a convertible preferred shares issued and outstanding—2,794,549 at june 30, 2021 and december 31, 2020 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2021 and december 31, 2020; class a convertible preferred shares issued and outstanding—2,794,549 at march 31, 2021 and december 31, 2020 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2020 and december 31, 2019; class a convertible preferred shares issued and outstanding—2,794,549 at december 31, 2020 and december 31, 2019 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2020 and december 31, 2019; class a convertible preferred shares issued and outstanding—2,794,549 at september 30, 2020 and december 31, 2019 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2020 and december 31, 2019; class a convertible preferred shares issued and outstanding—2,794,549 at june 30, 2020 and december 31, 2019 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| collaboration contract asset | 1,170,000 | 1,338,000 | 1,525,000 | 1,687,000 | 1,851,000 | 1,958,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2020 and december 31, 2019; class a convertible preferred shares issued and outstanding—2,794,549 at march 31, 2020 and december 31, 2019 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| long-term debt, current portion | 13,932,000 | 5,447,000 | 3,941,000 | 3,264,000 | 2,011,000 | 758,000 | 7,620,000 | 8,025,000 | 7,864,000 | 7,705,000 | 6,494,000 | 5,156,000 | 3,256,000 | 611,000 | 746,000 | 1,240,000 | 1,971,000 | |||||||||||||||||||||||||||||
| deferred rent | 3,401,000 | 2,441,000 | 1,462,000 | 1,303,000 | 1,347,000 | 1,090,000 | 821,000 | 543,000 | 101,000 | 99,000 | 97,000 | 42,000 | 58,000 | 75,000 | 91,000 | 100,000 | 76,000 | 101,000 | 118,000 | 153,000 | ||||||||||||||||||||||||||
| long-term debt, net of current portion | 9,469,000 | 10,958,000 | 11,601,000 | 12,835,000 | 14,069,000 | 14,789,000 | 6,676,000 | 1,081,000 | 4,610,000 | 6,676,000 | 8,700,000 | 12,635,000 | 14,539,000 | 16,414,000 | 9,389,000 | |||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2019 and december 31, 2018; designated class a convertible preferred shares—2,819,549 at december 31, 2019 and december 31, 2018; class a convertible preferred shares issued and outstanding—2,794,549 at december 31, 2019 and 2,819,549 at december 31, 2018 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2019 and december 31, 2018; class a convertible preferred shares issued and outstanding—2,794,549 at september 30, 2019 and 2,819,549 at december 31, 2018 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2019 and december 31, 2018; 2,819,549 class a convertible preferred shares issued and outstanding at june 30, 2019 and december 31, 2018 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2019 and december 31, 2018; 2,819,549 class a convertible preferred shares issued and outstanding at march 31, 2019 and december 31, 2018 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| current portion of cirm award liability | 2,106,000 | 1,284,000 | ||||||||||||||||||||||||||||||||||||||||||||
| current portion of deferred rent | 125,000 | 12,000 | 1,000 | 3,000 | 4,000 | 5,000 | 5,000 | 63,000 | 54,000 | 45,000 | 35,000 | 26,000 | 77,000 | 69,000 | 61,000 | 45,000 | ||||||||||||||||||||||||||||||
| current portion of deferred revenue | 7,588,000 | 3,250,000 | 1,776,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,105,000 | 2,401,000 | 2,451,000 | 2,105,000 | |||||||||||||||||||||||||||||||
| long–term debt, current portion | 2,438,000 | 8,187,000 | 7,550,000 | |||||||||||||||||||||||||||||||||||||||||||
| long–term debt, net of current portion | 12,446,000 | 14,808,000 | 2,501,000 | 10,688,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2018 and december 31, 2017; 2,819,549 class a convertible preferred shares issued and outstanding at december 31, 2018 and december 31, 2017 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| additional paid–in capital | 445,799,000 | 295,934,000 | 248,957,000 | 180,393,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2018 and december 31, 2017; 2,819,549 class a convertible preferred shares issued and outstanding at september 30, 2018 and december 31, 2017 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2018 and december 31, 2017; 2,819,549 class a convertible preferred shares issued and outstanding at june 30, 2018 and december 31, 2017 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2018 and december 31, 2017; 2,819,549 class a convertible preferred shares issued and outstanding at march 31, 2018 and december 31, 2017 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2017 and december 31, 2016; 2,819,549 class a convertible preferred shares issued and outstanding at december 31, 2017 and december 31, 2016 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2017 and december 31, 2016; 2,819,549 class a convertible preferred shares issued and outstanding at september 30, 2017 and december 31, 2016 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2017 and december 31, 2016; 2,819,549 class a convertible preferred shares issued and outstanding at june 30, 2017 and december 31, 2016 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2017 and december 31, 2016; 2,819,549 class a convertible preferred shares issued and outstanding at march 31, 2017 and december 31, 2016 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| repurchase liability for unvested equity awards | 1,000 | 9,000 | 21,000 | 33,000 | 57,000 | 69,000 | 82,000 | 106,000 | ||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2016 and december 31, 2015; 2,819,549 class a convertible preferred shares issued and outstanding at december 31, 2016; no shares issued or outstanding at december 31, 2015 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2016 and december 31, 2015; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2016 and december 31, 2015; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2016 and december 31, 2015; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at december 31, 2015 and december 31, 2014; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2015 and december 31, 2014; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2015 and december 31, 2014; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2015 and december 31, 2014; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at september 30, 2014 and december 31, 2013; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholder’s equity | 47,010,000 | 43,551,000 | ||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at june 30, 2014 and december 31, 2013; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; authorized shares—5,000,000 at march 31, 2014 and december 31, 2013; no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||||||||||||
| deficit accumulated during the development stage | ||||||||||||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ deficit | ||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 3,725,000 | |||||||||||||||||||||||||||||||||||||||||||||
| convertible notes, net of discount | 3,481,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock warrant liability | 163,000 | |||||||||||||||||||||||||||||||||||||||||||||
| exchangeable share liability | 2,885,000 | |||||||||||||||||||||||||||||||||||||||||||||
| long-term debt, less current portion | 250,000 | |||||||||||||||||||||||||||||||||||||||||||||
| long-term convertible notes | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 0.001 par value; authorized shares — 68,360,186 at september 30, 2013 and 62,200,000 at december 31, 2012; issued and outstanding shares — 44,967,690 at september 30, 2013 and december 31, 2012; liquidation preference of 58,518 at september 30, 2013 and december 31, 2012 | 56,526,000 | |||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ deficit: | ||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ deficit | ||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock and stockholders’ deficit | 23,040,000 |
We provide you with 20 years of balance sheets for Fate Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Fate Therapeutics. Explore the full financial landscape of Fate Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about Fate Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.